Topics

Leo to market AstraZeneca’s psoriasis treatment outside the EU

10:59 EDT 15 Aug 2019 | BioPharma-Reporter

Leo Pharma acquires exclusive rights to develop and market brodalumab, a treatment for psoriasis, outside of Europe.

Original Article: Leo to market AstraZeneca’s psoriasis treatment outside the EU

NEXT ARTICLE

More From BioPortfolio on "Leo to market AstraZeneca’s psoriasis treatment outside the EU"

Quick Search

Relevant Topic

Alzumab (Itolizumab)
Biocon Launches ALZUMAb™ - a ‘First in Class’ Novel Biologic Treatment for Psoriasis Patients in India • ALZUMAb™-World's first novel anti-CD6 antibody developed by Biocon to address a large unmet need for th...